Abstract
Changes in retinal nerve fiber layer (RNFL) thickness have been reported in patients with mild cognitive impairment (MCI), the pre-dementia stage of Alzheimer’s disease (AD). However, whether RNFL thickness is associated with specific cognitive impairment of MCI patients remains unknown. Therefore, we set out to investigate the potential association between RNFL thickness and episodic memory in MCI patients. Seventy five older adults (mean age 74 ± 3 years, 55% men) were included in the study. Fifty-two participants had normal cognition (NC), and 23 participants were diagnosed with MCI. RNFL thickness was obtained by optical coherence tomography measurement. Cognitive function was evaluated by the Repeatable Battery for the Assessment of Neuropsychological Status on the same day of the optical examination. We found that nasal quadrant RNFL thickness was positively associated with episodic memory scores in the participants with normal cognition: word list learning (r=0.392, p=0.004) and story recall (r=0.307, p=0.027). In the participants with MCI, however, the inferior quadrant RNFL thickness was inversely associated with the episodic memory score: word list learning (r=-0.652, p=0.001), story memory (r=-0.429, p=0.041), and story recall (r=-0.502, p=0.015,). The findings from this pilot study suggest that the inferior quadrant RNFL thickness was associated with specific episodic memory in MCI patients and could serve as a biomarker of MCI and AD. These findings would promote more studies to determine the potential application of RNFL as an AD biomarker.
Keywords: Episodic memory, mild cognitive impairment, retinal nerve fiber layer thickness.
Current Alzheimer Research
Title:Retinal Nerve Fiber Layer Thickness is Associated with Episodic Memory Deficit in Mild Cognitive Impairment Patients
Volume: 11 Issue: 3
Author(s): Yuan Shen, Liang Liu, Yan Cheng, Wei Feng, Zhongyong Shi, Yikang Zhu, Wenyuan Wu and Chunbo Li
Affiliation:
Keywords: Episodic memory, mild cognitive impairment, retinal nerve fiber layer thickness.
Abstract: Changes in retinal nerve fiber layer (RNFL) thickness have been reported in patients with mild cognitive impairment (MCI), the pre-dementia stage of Alzheimer’s disease (AD). However, whether RNFL thickness is associated with specific cognitive impairment of MCI patients remains unknown. Therefore, we set out to investigate the potential association between RNFL thickness and episodic memory in MCI patients. Seventy five older adults (mean age 74 ± 3 years, 55% men) were included in the study. Fifty-two participants had normal cognition (NC), and 23 participants were diagnosed with MCI. RNFL thickness was obtained by optical coherence tomography measurement. Cognitive function was evaluated by the Repeatable Battery for the Assessment of Neuropsychological Status on the same day of the optical examination. We found that nasal quadrant RNFL thickness was positively associated with episodic memory scores in the participants with normal cognition: word list learning (r=0.392, p=0.004) and story recall (r=0.307, p=0.027). In the participants with MCI, however, the inferior quadrant RNFL thickness was inversely associated with the episodic memory score: word list learning (r=-0.652, p=0.001), story memory (r=-0.429, p=0.041), and story recall (r=-0.502, p=0.015,). The findings from this pilot study suggest that the inferior quadrant RNFL thickness was associated with specific episodic memory in MCI patients and could serve as a biomarker of MCI and AD. These findings would promote more studies to determine the potential application of RNFL as an AD biomarker.
Export Options
About this article
Cite this article as:
Shen Yuan, Liu Liang, Cheng Yan, Feng Wei, Shi Zhongyong, Zhu Yikang, Wu Wenyuan and Li Chunbo, Retinal Nerve Fiber Layer Thickness is Associated with Episodic Memory Deficit in Mild Cognitive Impairment Patients, Current Alzheimer Research 2014; 11 (3) . https://dx.doi.org/10.2174/1567205011666140131114418
DOI https://dx.doi.org/10.2174/1567205011666140131114418 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease
Current Pharmaceutical Design Homocysteine in Neurology: From Endothelium to Neurodegeneration
Current Nutrition & Food Science Current Advances in Vehicles for Brain Gene Delivery
Current Gene Therapy Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design Editorial: Current and Emerging Therapeutics in AD
Current Alzheimer Research Principles of Clinical Management of Patent Ductus Arteriosus in Extremely Preterm Neonates
Current Pediatric Reviews Diagnosing and Treating Depression in Older and Oldest Old
Current Pharmaceutical Design The Role of Renal Nerve Ablation for the Management of Resistant Hypertension and other Disease Conditions: Benefits and Concerns
Current Vascular Pharmacology Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology Cognition in Non-Demented Diabetic Older Adults
Current Aging Science Carbonic Anhydrase Inhibitors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents What is Tobacco Smoke? Sociocultural Dimensions of the Association with Cardiovascular Risk
Current Pharmaceutical Design Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Caveolin-1 in Stroke Neuropathology and Neuroprotection: A Novel Molecular Therapeutic Target for Ischemic-Related Injury
Current Vascular Pharmacology Hypertension in Hemodialysis Patients
Current Hypertension Reviews Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses Advances in Drug Safety
Current Pharmaceutical Design Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research